Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Ann Surg Oncol. 2016 Jul 12;23(10):3239–3246. doi: 10.1245/s10434-016-5397-7

TABLE 3.

Outcome data in the pre- and post-guideline study periods

Factor/Outcome Overall Pre-Study Period (n = 504) Post-Study Period (n = 701) p-value
Margin width, invasive* 0.797
 - Negative (> 1 mm) 1063 (88.2) 441 (87.5) 622 (88.7)
 - Close (≤ 1 mm) 83 (6.9) 37 (7.3) 46 (6.6)
 - Positive 59 (4.9) 26 (5.2) 33 (4.7)
Margin width, DCIS 0.086
 - Negative (> 1 mm) 954 (79.3) 384 (76.5) 570 (81.3)
 - Close (≤ 1 mm) 196 (16.3) 90 (17.9) 106 (15.1)
 - Positive 53 (4.4) 28 (5.6) 25 (3.6)
Number of re-excisions 0.017
 - 0 991 (82.2) 396 (78.6) 595 (84.9)
 - 1 195 (16.2) 97 (19.2) 98 (14)
 - 2 16 (1.3) 10 (2) 6 (0.9)
 - ≥ 3 3 (0.2) 1 (0.2) 2 (0.3)
Mastectomy†† (performed) 8 (0.7) 2 (0.4) 6 (0.9) 0.480
*

Width of closest margin, invasive component only

Width of closest margin, DCIS component only

††

Mastectomy performed following attempted breast-conserving surgery

DCIS, ductal carcinoma in situ